NCT00398112
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +16 more
- Locations
-
- North Central Cancer Treatment Group Rochester, Minnesota, United States
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
1,435 public trials
165 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT00802737
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- GSK Investigational Site Örebro, Sweden
- GSK Investigational Site Stockholm, Sweden
NCT00600964
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of CA- San Diego La Jolla, California, United States
- Lombardi Cancer Center Washington D.C., District of Columbia, United States
- Milton S Hershey Medical Center Penn State Cancer Institute Hershey, Pennsylvania, United States
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00290810
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +15 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538
- Conditions
- Adnexal Diseases, Anemia, Blast Crisis, +110 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00003572
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
Completed
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003962
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT01231919
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Completed
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
NCT00003174
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States
NCT01161511
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Medical College of Georgia Augusta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States